TY  - CHAP
M1  - Book, Section
TI  - Chronic Myeloid Leukemia
A1  - Damon, Lloyd E.
A1  - Andreadis, Charalambos Babis
A2  - Papadakis, Maxine A.
A2  - McPhee, Stephen J.
A2  - Rabow, Michael W.
Y1  - 2021
N1  - 
T2  - Current Medical Diagnosis & Treatment 2021
AB  - Key  Clinical  Updates  in  Chronic  Myeloid  LeukemiaIn  patients  with  chronic  myeloid  leukemia  who  have  not  responded  to  treatment  with  multiple  tyrosine  kinase  inhibitors,  the  novel  allosteric  inhibitor  asciminib  can  be  tried.  It  has  shown  a  54%  complete  hematologic  response  rate  and  a  48%  sustained  major  molecular  response  in  heavily  pretreated  patients.  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2022/06/28
UR  - accessmedicine.mhmedical.com/content.aspx?aid=1175800568
ER  -